Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Haselmeier Acquires Drug Manufacturing License | Contract Pharma

What are you searching for?

Sign in
Breaking News

Haselmeier Acquires Drug Manufacturing License

Now offers assembly, labeling and packaging services for pharma/biopharma

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Haselmeier, a provider of self-injection devices, has been granted a drug manufacturing license at its production site in Buchen, Odenwald, in accordance with §13 of the Medicines Act (Arzneimittelgesetz – AMG) or according to Art. 40 of Directive 2001/83/EC. The company can now offer pharmaceutical and biopharmaceutical companies an assembly, labeling and packaging service.

Konrad Betzler, chief quality officer of Haselmeier, said,  “I am pleased that, after extensive preparatory work and in close coordination with the responsible GMP supervisory authority, we have now received the manufacturing permit.”

Haselmeier will assemble the cartridges supplied by customers for the respective therapies with the injection pens as well as label and package the combination products. This service also includes the manufacture of batches for stability testing.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics